echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Combination of DNA methyltransferase inhibitor decitabine and PAS1-30nt-RNA inhibits breast cancer growth

    Combination of DNA methyltransferase inhibitor decitabine and PAS1-30nt-RNA inhibits breast cancer growth

    • Last Update: 2022-04-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On March 21 , 2022 , Professor Zhang Hongquan's team from Peking University School of Basic Medicine published a long research paper titled "The DNMT1-PAS1- PH20 axis drives breast cancer growth and metastasis" in the journal Signal Transduction and Targeted Therapy .


    Working model: The role and mechanism of DNMT1-PAS1-PH20 regulatory axis in breast tumor growth and metastasis.


    The study found that DNA methyltransferase 1 (DNMT1) inhibits the transcription of PAS1 by binding and methylating the promoter of long non-coding RNA-PAS1 , and PAS1 inhibits breast cancer growth and metastasis .


    Fu Yenan, a doctoral student at Peking University School of Basic Medicine, Zhang Qian, a master student, and Liu Xiao, an attending physician at Peking University Third Hospital, are the co-first authors of this article.



    Original link: https://doi.


    (Peking University School of Basic Medicine)


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.